Clinical Trials Browser

Phase 1/2 × Not yet recruiting × ribociclib × Clear all

NCT07164976 2025-09-10

Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer

Phase 1/2 Not yet recruiting

Breast Neoplasms